Dalal Nesheiwat

Dalal Nesheiwat is an accomplished professional in the pharmaceutical industry, currently serving as Vice President and Global Head of Clinical Science at Daiichi Sankyo US since March 2022, focusing on R&D in oncology and hematology. Prior experience includes roles as Adjunct Faculty at LIU Brooklyn, Executive Director of Hematology Global Medical Affairs at Bristol Myers Squibb, and Senior Director at Celgene, where key contributions involved leadership in lymphoma and hematology developments. Dalal has also held significant positions at KYOWA KIRIN and Novartis, with a strong background in clinical development and regulatory submissions. Dalal earned a PharmD degree from Rutgers University.